New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous; bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: sodium chloride sodium hydroxide water for injection active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - bupivacaine - bupivacaine - long acting local anaesthetic.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - adrenaline acid tartrate; bupivacaine hydrochloride; adrenaline -

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - bupivacaine hydrochloride monohydrate 0.132% equivalent to 0.125% anhydrous - solution for infusion - 0.125 % - active: bupivacaine hydrochloride monohydrate 0.132% equivalent to 0.125% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous - solution for infusion - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - surgical anaesthesia - epidural block for surgery. - field block (minor and major nerve blocks and infiltration).

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - bupivacaine hydrochloride monohydrate 0.396% equivalent to 0.375% anhydrous - solution for injection - 0.375 % - active: bupivacaine hydrochloride monohydrate 0.396% equivalent to 0.375% anhydrous excipient: sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - bupivacaine hydrochloride monohydrate 0.792% equivalent to 0.75% anhydrous;   - solution for injection - 0.75 % - active: bupivacaine hydrochloride monohydrate 0.792% equivalent to 0.75% anhydrous   excipient: sodium chloride sodium hydroxide water for injection

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - bupivacaine hcl - injection - 5 mg/ml - bupivacaine hcl 5 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - bupivacaine hydrochloride; adrenaline acid tartrate; bupivacaine hydrochloride anhydrous -

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - bupivacaine - bupivacaine - spinal anaesthesia for surgery, e.g. urological and lower limb surgery, lasting 2-3 hours, abdominal surgery lasting 45-60 minutes.